NASDAQ
Enlivex Therapeutics Ltd. (ENLV) has a fcf yield of -32.62% as of Monday, August 3, 2026. This represents a 20.16% increase compared to its 12-month average of -40.86%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.